Abstract Objective Copy number variations (CNVs) detected by high-resolution single
nucleotide polymorphism microarrays (SNP arrays) have been associated with congenital …

Objectives: To evaluate the usefulness of single-nucleotide polymorphism (SNP) array for
prenatal genetic diagnosis of congenital heart defect (CHD), we used this approach to detect …

Objective This study aimed to detect genomic imbalances in fetuses with congenital heart
defect (CHD) by high‐resolution single‐nucleotide polymorphism (SNP) array. Methods A …

Background With the increasing availability of chromosomal microarray analysis (CMA) for
congenital heart defect (CHD), genetic testing now faces new challenges due to results with …

Objective This study aimed to examine the effectiveness of the SNP array for the prenatal
diagnosis of congenital heart disease (CHD) screened by echocardiography. Patients and …

Background: Congenital heart disease (CHD) is one of the most common birth defects;
however, the mechanisms underlying its development are poorly understood. Recently …

Objectives To evaluate the usefulness of array‐based comparative genomic hybridization
(aCGH) for prenatal genetic diagnosis of congenital heart disease (CHD), with and without …

In the prenatal diagnosis of chromosomal anomalies, karyotyping is increasingly being
replaced with or supplemented by chromosomal microarray analysis (CMA). CMA is used for …

Background Chromosomal microarray analysis (CMA) has emerged as a critical instrument
in prenatal diagnostic procedures, notably in assessing congenital heart diseases (CHD) …

Congenital heart defects (CHDs) appear in 8–10 out of 1000 live born newborns and are
one of the most common causes of deaths. In fetuses, the congenital heart defects are found …